HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: An 11-year follow-up;Soroprevalência e taxa de coinfecção do HTLV-1/2 em doadores de sangue de primeira vez brasileiros: 11 anos de estudo

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 54, Issue 3, 2012, Pages 123-129

  Pinto, Mariana Tomazini ^a,b   Rodrigues, Evandra Strazza ^a,b   Malta, Tathiane Maistro ^a,b   Azevedo, Rochele ^a   Takayanagui, Osvaldo Massaiti ^b   Valente, Vanderléia Bárbaro ^a   Ubiali, Eugênia Maria Amorim ^a   Covas, Dimas Tadeu ^a,b   Kashima, Simone ^a,b  

^a Regional Blood Center of Ribeirão Preto   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood donors; HTLV coinfection; HTLV 1 2; Seroprevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; BRAZIL; CHAGAS DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POLYMERASE CHAIN REACTION; SEROLOGY; SEROPREVALENCE; SEX DIFFERENCE; SYPHILIS; TREND STUDY; VIRUS DETECTION;

ADOLESCENT; ADULT; BLOOD DONORS; BRAZIL; COINFECTION; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84861926568     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652012000300002     Document Type: Article

References (43)

1. Alcantara Jr LC, Van Dooren S, Goncalves MS, Kashima S, Costa MC, Santos FL, et al. Globin haplotypes of human T-cell lymphotropic virus type I-infected individuals in Salvador, Bahia, Brazil, suggest a post-Columbian African origin of this virus. J Acquir Immune Defic Syndr. 2003;33:536-542.
2. Bangham CR, Osame M. Cellular immune response to HTLV-1. Oncogene. 2005;24:6035-6046.
3. Beilke MH. Retroviral coinfections: HIV and HTLV. Taking stock of more than a quarter century of research. AIDS Res Hum Retroviruses. 2012;28:139-146.
4. Bittencourt AL, Dourado I, Filho PB, Santos M, Valadao E, Alcantara LC, et al. Human T-cell lymphotropic virus type 1 infection among pregnant women in northeastern Brazil. J Acquir Immune Defic Syndr. 2001;26:490-494.
5. Borducchi DM, Kerbauy J, de Oliveira JS. Linfoma/leucemia de células T do adulto. Rev Assoc Med Bras. 1999;45:63-70.
6. Boschi-Pinto C, Stuver S, Okayama A, Trichopoulos D, Orav EJ, Tsubouchi H, et al. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J Infect Dis. 2000;181:35-41.
7. Brites C, Sampaio J, Oliveira A. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev. 2009;11:8-16.
8. Cardoso DF, Souza FV, Fonseca LA, Duarte AJ, Casseb J. Influence of human T-cell lymphotropic virus type 1 (HTLV-1) infection on laboratory parameters of patients with chronic hepatitis C virus. Rev Inst Med Trop Sao Paulo. 2009;51:325-329.
9. Carneiro-Proietti AB, Ribas JG, Catalan-Soares BC, Martins ML, Brito-Melo GE, Martins-Filho OA, et al. Infecção e doença pelos virus linfotrópicos humanos de celulas T (HTLV-I/II) no Brasil. Rev Soc Bras Med Trop. 2002;35:499-508.
10. Casoli C, Pilotti E, Bertazzoni U. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev. 2007;9:140-149.
11. Catalan-Soares B, Carneiro-Proietti AB, Proietti FA, Interdisciplinary HTLV Research Group. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saude Publica. 2005;21:926-931.
12. Catalan-Soares BC, Proietti FA, Carneiro-Proietti ABF. Human T-cell lymphotropic viruses (HTLV) in the last decade (1990-2000): epidemiological aspects. Rev Bras Epidemiol. 2001;4:81-95.
13. de Thé G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses. 1993;9:381-386.
14. Dourado I, Andrade T, Carpenter CL, Galvao-Castro B. Risk factors for human T cell lymphotropic virus type I among injecting drug users in northeast Brazil: possibly greater efficiency of male to female transmission. Mem Inst Oswaldo Cruz. 1999;94:13-18.
15. Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvao-Castro B. HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr. 2003;34:527-531.
16. Eiraku N, Novoa P, da Costa Ferreira M, Monken C, Ishak R, da Costa Ferreira O, et al. Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2. J Virol. 1996;70:1481-1492.
17. Ferreira Junior OC, Vaz RS, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, et al. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from Sao Paulo, Brazil. Transfusion. 1995;35:258-263.
18. Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 2000;182:1343-1649.
19. Galvao-Castro B, Loures L, Rodrigues LG, Sereno A, Ferreira Junior OC, Franco LG, et al. Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion. 1997;37:242-243.
20. Gudo ES, Bhatt NB, Bila DR, Abreu CM, Tanuri A, Savino W, et al. Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? BMC Infect Dis. 2009;9:211.
21. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982;218(4572):571-573.
22. Kaplan JE, Khabbaz RF, Murphy EL, Hermansen S, Roberts C, Lal R, et al. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:193-201.
23. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet. 1990;336(8727):1345-1347.
24. Lima LH, Viana MC. Prevalence and risk factors for HIV, syphilis, hepatitis B, hepatitis C, and HTLV-I/II infection in low-income postpartum and pregnant women in Greater Metropolitan Vitoria, Espirito Santo State, Brazil. Cad Saude Publica. 2009;25:668-676.
25. Lima MA, Bica RB, Araujo AQ. Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis. J Neurol Neurosurg Psychiatry. 2005;76:294-296.
26. Mahieux R, Gessain A. Les nouveaux retrovirus humains HTLV-3 et HTLV-4. Med Trop (Mars). 2005;65:525-528.
27. Mahieux R, Gessain A. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol Biol (Paris). 2009;57:161-166.
28. Mariette X, Agbalika F, Zucker-Franklin D, Clerc D, Janin A, Cherot P, et al. Detection of the tax gene of HTLV-I in labial salivary glands from patients with Sjogren's syndrome and other diseases of the oral cavity. Clin Exp Rheumatol. 2000;18:341-347.
29. Mochizuki M, Ono A, Ikeda E, Hikita N, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl 1):S50-S56.
30. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet. 1989;2(8673):1184-1187.
31. Moxoto I, Boa-Sorte N, Nunes C, Mota A, Dumas A, Dourado I, et al. Perfil sociodemográfico e comportamental de mulheres infectadas pelo HTLV-1 em Salvador, Bahia, uma área endêmica para HTLV. Rev Soc Bras Med Trop. 2007;40:37-41.
32. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989;1(8635):441.
33. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1(8488):1031-1032.
34. Pawson R, Mufti GJ, Pagliuca A. Management of adult T-cell leukaemia/lymphoma. Br J Haematol. 1998;100:453-458.
35. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415-7419.
36. Portelinha Filho AM, Nascimento CU, Tannouri TN, Troiani C, Ascencio EL, Bonfim R, et al. Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of Sao Paulo, Brazil. Mem Inst Oswaldo Cruz. 2009;104:960-966
37. Saito M, Nakagawa M, Kaseda S, Matsuzaki T, Jonosono M, Eiraku N, et al. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 2004;189:29-40.
38. Salles NA, Sabino EC, Barreto CC, Barreto AM, Otani MM, Chamone DF. Descarte de bolsas de sangue e prevalência de doenças infecciosas em doadores de sangue da Fundação Pró-Sangue /Hemocentro de São Paulo. Rev Panam Salud Publica. 2003;13:111-116.
39. Soares BC, Proietti AB, Proietti FA, Interdisciplinary HTLV-I/II Research Group. HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population. Rev Saude Publica. 2003;37:470-476.
40. Switzer WM, Pieniazek D, Swanson P, Samdal HH, Soriano V, Khabbaz RF, et al. Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol. 1995;69:621-632.
41. Victoria MB, Victoria F da S, Torres KL, Kashima S, Covas DT, Malheiro A. Epidemiology of HIV/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas. Braz J Infect Dis. 2010;14:135-140.
42. Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, et al. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci USA. 2005;102:7994-7999.
43. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA. 1984;81:2534-2537.